【is a blackstone considered open flame】What Should You Know About The Future Of AstraZeneca PLC’s (LON:AZN)?
After AstraZeneca PLC’s (
LON:AZN
) earnings announcement in September 2018,is a blackstone considered open flame analysts seem cautiously optimistic, with profits predicted to increase by 10.0% next year against the past 5-year average growth rate of 7.6%. With trailing-twelve-month net income at current levels of US$3.0b, we should see this rise to US$3.3b in 2020. I will provide a brief commentary around the figures and analyst expectations in the near term. For those interested in more of an analysis of the company, you can
research its fundamentals here
.
View our latest analysis for AstraZeneca
Can we expect AstraZeneca to keep growing?
Longer term expectations from the 25 analysts covering AZN’s stock is one of positive sentiment. Given that it becomes hard to forecast far into the future, broker analysts tend to project ahead roughly three years. To understand the overall trajectory of AZN’s earnings growth over these next fews years, I’ve fitted a line through these analyst earnings forecast to determine an annual growth rate from the slope.
LSE:AZN Future Profit January 1st 19
From the current net income level of US$3.0b and the final forecast of US$6.5b by 2022, the annual rate of growth for AZN’s earnings is 27%. EPS reaches $3.99 in the final year of forecast compared to the current $2.37 EPS today. In 2022, AZN’s profit margin will have expanded from 13% to 22%.
Next Steps:
Future outlook is only one aspect when you’re building an investment case for a stock. For AstraZeneca, there are three relevant aspects you should look at:
Financial Health
: Does it have a healthy balance sheet? Take a look at our
free balance sheet analysis with six simple checks
on key factors like leverage and risk.
Valuation
: What is AstraZeneca worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The
intrinsic value infographic in our free research report
helps visualize whether AstraZeneca is currently mispriced by the market.
Other High-Growth Alternatives
: Are there other high-growth stocks you could be holding instead of AstraZeneca? Explore
our interactive list of stocks with large growth potential
to get an idea of what else is out there you may be missing!
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at
.
View comments
下一篇:Global stocks tumble as US-China tensions escalate
相关文章:
- Fatalities on commercial passenger aircraft rise in '18
- French regulator orders Google to review ads policies
- Oil Price Fundamental Daily Forecast – Stock Market Weakness Weighing on Crude Prices
- European shares edge up as earnings overcome China worries
- Before You Buy Youngevity International, Inc. (NASDAQ:YGYI), Consider Its Volatility
- Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James
- BRIEF-My EG Services Says Unit Received Letter Of No Objection In Relation To Launch Of iPpayEasy E-Wallet
- Asian markets rise on China-US trade prospects
- Is Changan Minsheng APLL Logistics Co., Ltd.’s (HKG:1292) CEO Salary Justified?
- Factbox - What to expect from China's annual meeting of parliament next week
相关推荐:
- Global 5G infrastructure market size to reach USD 47.6 Billion by 2027
- Do Institutions Own InnoTek Limited (SGX:M14) Shares?
- Thomas Reid Leaving Davis Polk to Join Comcast as Senior EVP
- Brunswick (BC) Q4 2018 Earnings Conference Call Transcript
- Warren calls out Sanders for supporters' ‘really ugly’ online attacks
- Hawaii avocado industry expects growth as exports begin
- Does Asian American Medical Group Limited (ASX:AJJ) Have A High Beta?
- Is It Too Late To Consider Buying Huami Corporation (NYSE:HMI)?
- Buy Ferrari Stock After Scuderia-Velas NFT deal?
- Dollar steady with eyes on Fed for rate clues; kiwi higher
- Global Vision Care Market (2020 to 2025) - Featuring Alcon, Carl Zeiss and Hoya Among Others
- Nokia draws $560 million R&D loan for 5G
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Opera Limited (OPRA) Investors With Losses to Contact its Attorneys: Important Class Action Deadline Approaching
- Akoustis Reports Third Quarter FY20 Results
- Exclusive: StanChart says CEO Winters will stay to execute current strategy
- Live Oak Acquisition Corp. II Announces Pricing of Upsized $220,000,000 Initial Public Offering
- OneWater Marine Inc. Announces Fiscal Fourth Quarter and Full-Year 2020 Earnings Release Date and Conference Call Information
- Analysts Just Slashed Their China Cinda Asset Management Co., Ltd. (HKG:1359) EPS Numbers
- Sun Summit Minerals Phase 2 Drilling Update and Completion of IP Survey at the Buck Property
- Endurance International (EIGI) Q3 Earnings and Revenues Surpass Estimates